A61K 51/1021
Against cytokines
Official title: {against cytokines, e.g. growth factors, VEGF, TNF, lymphokines or interferons}
A61K51/1021 (Against cytokines) appears on 69 US grants and 119 published applications in this corpus.
Search patents in A61K- Granted patents
- 69
- Published applications
- 119
- Assignees
- 60
- Inventors
- 221
- Latest grant
- 30 Jul 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 4 |
| 2010 | 2 | 4 |
| 2011 | 1 | 4 |
| 2012 | 2 | 9 |
| 2013 | 3 | 6 |
| 2014 | 5 | 8 |
| 2015 | 3 | 9 |
| 2016 | 8 | 13 |
| 2017 | 10 | 18 |
| 2018 | 5 | 3 |
| 2019 | 4 | 4 |
| 2020 | 9 | 6 |
| 2021 | 4 | 4 |
| 2022 | 3 | 7 |
| 2023 | 3 | 2 |
| 2024 | 3 | 7 |
| 2025 | 0 | 2 |
| 2026 | 0 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Labeling of antibodies30 Jul 2024US 12,048,753 B2Whitehead Institute for Biomedical Research
- Pharmaceutical compositions and related methods of delivery21 May 2024US 11,986,529 B2Amryt Endo, Inc.
- Pharmaceutical compositions and related methods of delivery30 Apr 2024US 11,969,471 B2Amryt Endo, Inc.
- Methods for determining biodistribution of intravitreal administered medicaments5 Sep 2023US 11,744,908 B2
- In vivo immunoimaging of interferon-gamma13 Jun 2023US 11,672,877 B2Wayne State University
- Antibodies targeting s100 proteins and uses thereof1 Oct 2026US 2026/0297172 A1Albert Einstein College of Medicine
- Anti-tslp nanobodies and their applications17 Sep 2026US 2026/0274941 A1Shanghai Novamab Biopharmaceuticals Co., Ltd.
- Method for producing radioactive pharmaceutical composition2 Jul 2026US 2026/0183436 A1Nihon Medi-Physics Co., Ltd.
- Anti-s100a8/a9 antibody and use thereof2 Jul 2026US 2026/0184777 A1Beijing Sungen Biomedical Technology Co., Ltd.
- Cd73 (nt5e) targeting polypeptides22 Jan 2026US 2026/0022186 A1The University of Chicago
Most cited
By later US patents
- Dual variable domain immunoglobulins and uses thereof65US 8,735,546 B2AbbVie Inc. · 2014
- Methods for diagnosis using anti-cytokine receptor antibodies62US 7,727,528 B2Early Detection, LLC · 2010
- Carrier-antibody compositions and methods of making and using the same58US 9,446,148 B2Mayo Foundation for Medical Education and Research · 2016
- Carrier-antibody compositions and methods of making and using the same58US 9,533,058 B2Mayo Foundation for Medical Education and Research · 2017
- Carrier-antibody compositions and methods of making and using the same58US 9,566,350 B2Mayo Foundation for Medical Education and Research · 2017